Chemoprophylaxis of Cryptosporidium parvum infection with paromomycin in kids and immunological study.
AUTOR(ES)
Mancassola, R
RESUMO
The anticryptosporidial activity of paromomycin, a natural antibiotic weakly absorbed when administered per os, was assessed in goat kids experimentally infected once via the oral route with 10(6) Cryptosporidium parvum oocysts. Paromomycin used prophylactically at a dose of 100 mg/kg of body weight per day from day-1 to day 10 (day 0 was the inoculation day) prevented infection during the period of drug administration. A delayed low infection was suggested by an antibody rise, but the infection developed below the microscopic detection limits. This low parasite development induced a partial immunity in kids, which reacted immunologically to a challenge on day 21 without symptoms or detectable oocyst shedding. So, paromomycin is a good candidate for field trials because it is prophylactically effective against experimental C. parvum infection and well tolerated by animals. This drug would be useful in an adapted form as an anticryptosporidial agent for neonatal ruminants.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=162488Documentos Relacionados
- Comparative Efficacy Evaluation of Dicationic Carbazole Compounds, Nitazoxanide, and Paromomycin against Cryptosporidium parvum Infections in a Neonatal Mouse Model
- INTESTINAL AND PULMONARY INFECTION BY Cryptosporidium parvum IN TWO PATIENTS WITH HIV/AIDS
- Paromomycin and Geneticin Inhibit Intracellular Cryptosporidium parvum without Trafficking through the Host Cell Cytoplasm: Implications for Drug Delivery
- Eradication of Cryptosporidium parvum Infection by Mice with Ovalbumin-Specific T Cells
- Murine infection model for maintenance and amplification of Cryptosporidium parvum oocysts.
